Advanced Therapies To Be Driven By Innovation-First Mindset

To maximise the patient access when it comes to advanced therapies, improved data harmonization and a skilled taskforce hold the key as per a recent report.

The New Pharma Legislation - A Long-Term Robust Approach

The new pharmaceutical legislation gives traction to new medicines as well as medical therapies and the idea is to do so without compromising patient safety.

To Lower Drug Prices, Biden Administration Targets Patents

The White House is supporting the policy that will enable the US government to sidestep the patent protection framework so as to lower the prices of drugs.

Harnessing Data Science Insights to Drive OSD Innovation

Oral solid dosage (OSD) formats offer convenient administration as well as accurate and uniform dosing, which has contributed to their continued popularity and their status as the most globally used drug form.

Vetter joins Science Based Targets Initiative (SBTi)

Ravensburg, December 5, 2023: Vetter, a leading globally operating Contract Development and Manufacturing Organization (CDMO), has joined the Science Based Targets Initiative (SBTi) membership.

Recipharm announces collaboration with Oz-UK to accelerate the development of low global warming potential pMDIs utilising HFA-152a propellant

Global contract development and manufacturing organisation (CDMO), Recipharm has announced a collaboration with Oz-UK, a Contract Research Organisation (CRO).